The firm laid off all of its employees last month and inked agreements with top executives for part-time consulting work.

The firm intends to use the net proceeds from the offering for working capital and other general corporate purposes.

The firm's E1000 Dx Digital Pathology Solution consists of an automated scanner, whole-slide image viewer, and image management and viewing software.

Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.

Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.

The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.

Last week, readers were most interested in a story about Pfizer shuttering the Lucira Health business that it acquired in 2023.

One ACED project is focused on developing biomarkers for the early detection of ovarian cancer, with the goal of commercializing any resulting tests.